Simultaneous Sequential Compression Device Segment to Dominate North America Home Sequential Compression Devices Market during 2020–2028
According to The Insight Partners market research study on “North America Home Sequential Compression Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Device Type, Type, and Application” is expected to reach US$ 691.88 million by 2028 from 428.66 US$ million in 2021. The market is estimated to grow at a CAGR of 7.1% from 2021 to 2028. The report provides trends prevailing in the North America home sequential compression devices market along with the drivers and restraints pertaining to the market growth. Occurrence of lymphatic and venous disorders is the major factor driving the growth of the North America home sequential compression devices market. However, issues presence of other therapies hinders the growth of North America home sequential compression devices market.
The North America home sequential compression devices market is segmented on the bases of device type, type, application, and country. The North America home sequential compression devices market, by type is segmented into alternate sequential compression device (ASCD), simultaneous sequential compression device (SSCD). The simultaneous sequential compression device (SSCD) segment held the largest share of the market in 2021. North America home sequential compression devices market based on the type is segmented into standard and portable. In 2021, the standard segment is likely to hold the largest share of the market. The North America home sequential compression devices market by application, is segmented into deep vein thrombosis (DVT), lymphedema management, chronic venous insufficiency (CVI) and others. The deep vein thrombosis (DVT), segment is likely to hold the largest share of the market in 2021. The North America home sequential compression devices market, by country is segmented into US, Canada, and Mexico.
The fear of COVID-19 has hit the business across the world. COVID-19 virus outbreak was first observed in December 2019 in Wuhan (China), and it has spread to ~100 countries across the world, with the World Health Organization (WHO) stating it as a public health emergency. The global impacts of COVID-19 are being felt across several markets. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. North America has been witnessing a growing number of COVID-19 cases since its outbreak. For instance, according to Worldometer, the number of cases increased to 34,540,845, with 620,249 deaths reported in the US as of July 1st, 2021. The cases are also increasing in Mexico and Canada. In Mexico, the cases have reached 2,519,269, with 233,047 deaths. Similarly, in Canada, there are about 1,415,284 COVID cases, with 26,295 deaths reported so far. The chaotic situation was created in the medical industry across the countries, the demand for diagnostics and therapeutic devices have dramatically increased in all healthcare settings. Home based diagnostic and therapeutic has also witnessing surge in demand. This is expected to support home sequential compression devices market growth, as most of the individuals opting for home care therapeutics due to fear of hospital acquired infection.
AIROS Medical; Arjo Medical Devices; BIOCOMPRESSION SYSTEMS; Breg Inc.; Cardinal Health Inc; DJO Global, Inc.; DSMAREF CO.LTD; Mego Afek ltd.; Precision Medical Products; and Tactile Medical are among the leading companies in the North America home sequential compression devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, The SVANTEK Team welcomed OHD, its new distributor situated in Birmingham, Alabama in the United States, in February 2021. AIROS Medical, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its updated AIROS 8 Sequential Compression Therapy device and garment system.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com